228 related articles for article (PubMed ID: 19805030)
1. SH3TC2/KIAA1985 protein is required for proper myelination and the integrity of the node of Ranvier in the peripheral nervous system.
Arnaud E; Zenker J; de Preux Charles AS; Stendel C; Roos A; Médard JJ; Tricaud N; Kleine H; Luscher B; Weis J; Suter U; Senderek J; Chrast R
Proc Natl Acad Sci U S A; 2009 Oct; 106(41):17528-33. PubMed ID: 19805030
[TBL] [Abstract][Full Text] [Related]
2. Exclusive expression of the Rab11 effector SH3TC2 in Schwann cells links integrin-α6 and myelin maintenance to Charcot-Marie-Tooth disease type 4C.
Vijay S; Chiu M; Dacks JB; Roberts RC
Biochim Biophys Acta; 2016 Jul; 1862(7):1279-90. PubMed ID: 27068304
[TBL] [Abstract][Full Text] [Related]
3. AAV9-mediated SH3TC2 gene replacement therapy targeted to Schwann cells for the treatment of CMT4C.
Georgiou E; Kagiava A; Sargiannidou I; Schiza N; Stavrou M; Richter J; Tryfonos C; Heslegrave A; Zetterberg H; Christodoulou C; Kleopa KA
Mol Ther; 2023 Nov; 31(11):3290-3307. PubMed ID: 37641403
[TBL] [Abstract][Full Text] [Related]
4. The phenotype of Charcot-Marie-Tooth disease type 4C due to SH3TC2 mutations and possible predisposition to an inflammatory neuropathy.
Houlden H; Laura M; Ginsberg L; Jungbluth H; Robb SA; Blake J; Robinson S; King RH; Reilly MM
Neuromuscul Disord; 2009 Apr; 19(4):264-9. PubMed ID: 19272779
[TBL] [Abstract][Full Text] [Related]
5. Gene replacement therapy in a model of Charcot-Marie-Tooth 4C neuropathy.
Schiza N; Georgiou E; Kagiava A; Médard JJ; Richter J; Tryfonos C; Sargiannidou I; Heslegrave AJ; Rossor AM; Zetterberg H; Reilly MM; Christodoulou C; Chrast R; Kleopa KA
Brain; 2019 May; 142(5):1227-1241. PubMed ID: 30907403
[TBL] [Abstract][Full Text] [Related]
6. SH3TC2, a protein mutant in Charcot-Marie-Tooth neuropathy, links peripheral nerve myelination to endosomal recycling.
Stendel C; Roos A; Kleine H; Arnaud E; Ozçelik M; Sidiropoulos PN; Zenker J; Schüpfer F; Lehmann U; Sobota RM; Litchfield DW; Lüscher B; Chrast R; Suter U; Senderek J
Brain; 2010 Aug; 133(Pt 8):2462-74. PubMed ID: 20826437
[TBL] [Abstract][Full Text] [Related]
7. Spine deformities in Charcot-Marie-Tooth 4C caused by SH3TC2 gene mutations.
Azzedine H; Ravisé N; Verny C; Gabrëels-Festen A; Lammens M; Grid D; Vallat JM; Durosier G; Senderek J; Nouioua S; Hamadouche T; Bouhouche A; Guilbot A; Stendel C; Ruberg M; Brice A; Birouk N; Dubourg O; Tazir M; LeGuern E
Neurology; 2006 Aug; 67(4):602-6. PubMed ID: 16924012
[TBL] [Abstract][Full Text] [Related]
8. Novel mutations in SH3TC2 in a young Japanese girl with Charcot-Marie-Tooth disease type 4C.
Ichikawa K; Numasawa K; Takeshita S; Hashiguchi A; Takashima H
Pediatr Int; 2016 Nov; 58(11):1252-1254. PubMed ID: 27882734
[TBL] [Abstract][Full Text] [Related]
9. Haplotype-specific modulation of a SOX10/CREB response element at the Charcot-Marie-Tooth disease type 4C locus SH3TC2.
Brewer MH; Ma KH; Beecham GW; Gopinath C; Baas F; Choi BO; Reilly MM; Shy ME; Züchner S; Svaren J; Antonellis A
Hum Mol Genet; 2014 Oct; 23(19):5171-87. PubMed ID: 24833716
[TBL] [Abstract][Full Text] [Related]
10. Sh3tc2 deficiency affects neuregulin-1/ErbB signaling.
Gouttenoire EA; Lupo V; Calpena E; Bartesaghi L; Schüpfer F; Médard JJ; Maurer F; Beckmann JS; Senderek J; Palau F; Espinós C; Chrast R
Glia; 2013 Jul; 61(7):1041-51. PubMed ID: 23553667
[TBL] [Abstract][Full Text] [Related]
11. Neuromuscular Junction Changes in a Mouse Model of Charcot-Marie-Tooth Disease Type 4C.
Cipriani S; Phan V; Médard JJ; Horvath R; Lochmüller H; Chrast R; Roos A; Spendiff S
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30562927
[TBL] [Abstract][Full Text] [Related]
12. Screening for SH3TC2 gene mutations in a series of demyelinating recessive Charcot-Marie-Tooth disease (CMT4).
Piscosquito G; Saveri P; Magri S; Ciano C; Gandioli C; Morbin M; Bella DD; Moroni I; Taroni F; Pareyson D
J Peripher Nerv Syst; 2016 Sep; 21(3):142-9. PubMed ID: 27231023
[TBL] [Abstract][Full Text] [Related]
13. Missense mutations in the SH3TC2 protein causing Charcot-Marie-Tooth disease type 4C affect its localization in the plasma membrane and endocytic pathway.
Lupo V; Galindo MI; Martínez-Rubio D; Sevilla T; Vílchez JJ; Palau F; Espinós C
Hum Mol Genet; 2009 Dec; 18(23):4603-14. PubMed ID: 19744956
[TBL] [Abstract][Full Text] [Related]
14. Motor and sensory neuropathy due to myelin infolding and paranodal damage in a transgenic mouse model of Charcot-Marie-Tooth disease type 1C.
Lee SM; Sha D; Mohammed AA; Asress S; Glass JD; Chin LS; Li L
Hum Mol Genet; 2013 May; 22(9):1755-70. PubMed ID: 23359569
[TBL] [Abstract][Full Text] [Related]
15. Compound heterozygous mutations of SH3TC2 in Charcot-Marie-Tooth disease type 4C patients.
Lee AJ; Nam SH; Park JM; Kanwal S; Choi YJ; Lee HJ; Lee KS; Lee JE; Park JS; Choi BO; Chung KW
J Hum Genet; 2019 Sep; 64(9):961-965. PubMed ID: 31227790
[TBL] [Abstract][Full Text] [Related]
16. Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy.
Senderek J; Bergmann C; Stendel C; Kirfel J; Verpoorten N; De Jonghe P; Timmerman V; Chrast R; Verheijen MH; Lemke G; Battaloglu E; Parman Y; Erdem S; Tan E; Topaloglu H; Hahn A; Müller-Felber W; Rizzuto N; Fabrizi GM; Stuhrmann M; Rudnik-Schöneborn S; Züchner S; Michael Schröder J; Buchheim E; Straub V; Klepper J; Huehne K; Rautenstrauss B; Büttner R; Nelis E; Zerres K
Am J Hum Genet; 2003 Nov; 73(5):1106-19. PubMed ID: 14574644
[TBL] [Abstract][Full Text] [Related]
17. Mutational screening of the SH3TC2 gene in Greek patients with suspected demyelinating recessive Charcot-Marie-Tooth disease reveals a varied and unusual phenotypic spectrum.
Kontogeorgiou Z; Nikolaou K; Kartanou C; Breza M; Panas M; Karadima G; Koutsis G
J Peripher Nerv Syst; 2019 Mar; 24(1):125-130. PubMed ID: 30653784
[TBL] [Abstract][Full Text] [Related]
18. Screening for SH3TC2 variants in Charcot-Marie-Tooth disease in a cohort of Chinese patients.
Sun B; He ZQ; Li YR; Bai JM; Wang HR; Wang HF; Cui F; Yang F; Huang XS
Acta Neurol Belg; 2022 Oct; 122(5):1169-1175. PubMed ID: 33587240
[TBL] [Abstract][Full Text] [Related]
19. Clinical, in silico, and experimental evidence for pathogenicity of two novel splice site mutations in the SH3TC2 gene.
Laššuthová P; Gregor M; Sarnová L; Machalová E; Sedláček R; Seeman P
J Neurogenet; 2012 Sep; 26(3-4):413-20. PubMed ID: 22950825
[TBL] [Abstract][Full Text] [Related]
20. Implication of the SH3TC2 gene in Charcot-Marie-Tooth disease associated with deafness and/or scoliosis: Illustration with four new pathogenic variants.
Lerat J; Magdelaine C; Lunati A; Dzugan H; Dejoie C; Rego M; Beze Beyrie P; Bieth E; Calvas P; Cintas P; Delaubrier A; Demurger F; Gilbert-Dussardier B; Goizet C; Journel H; Laffargue F; Magy L; Taithe F; Toutain A; Urtizberea JA; Sturtz F; Lia AS
J Neurol Sci; 2019 Nov; 406():116376. PubMed ID: 31634715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
